Caris Life Sciences Publishes Study Highlighting the Value of Comprehensive Molecular Profiling in Characterizing ESR1-Mutated Metastatic Breast Cancer

Barchart · 11/09 07:30

Findings suggest ESR1 variant type, number of mutations and estrogen receptor (ER) pathway activity may provide information beyond ESR1 mutation status alone

Read more at prnewswire.com

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.